Research has identified proinflammatory microenvironments as a potential origin of lung cancer. Studies have explored the role of cellular interactions, microbiota, and molecular mechanisms in the tumor microenvironment, including the impact on immunotherapy response. The findings also highlight the involvement of various factors, such as tumor-associated macrophage clusters and extracellular vesicles, in cancer development and potential treatment targets.